InvestorsHub Logo
Followers 1
Posts 160
Boards Moderated 0
Alias Born 10/17/2013

Re: epenephrine post# 22447

Tuesday, 12/03/2013 8:48:05 PM

Tuesday, December 03, 2013 8:48:05 PM

Post# of 427207
ep,

The following quote was taken from Forbes columnist Larry Husten the day the SPA agreement was rescinded.... "But if Amarin does abandon the trial, is there an alternative? Some cholesterol experts I’ve spoken with believe the NHLBI should pick up the trial if it is abandoned"

I find it strange that some cholesterol experts were already talking about saving this study the day the SPA was rescinded, yet the effects of Vascepa were downplayed by the FDA at the AdCom. Just seems strange to me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News